Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 12Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Breast 5Lymphoid 4Genitourinary 3Gastrointestinal 3Thoracic 1Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Lung Neoplasms 1370Carcinoma, Non-Small-Cell Lung 1080Breast Neoplasms 183Neoplasms 145Small Cell Lung Carcinoma 137Colorectal Neoplasms 104Adenocarcinoma of Lung 86Melanoma 84Prostatic Neoplasms 80Pancreatic Neoplasms 79Esophageal Neoplasms 70Head and Neck Neoplasms 69Ovarian Neoplasms 67Colonic Neoplasms 67Stomach Neoplasms 63Urinary Bladder Neoplasms 49Neoplasm Metastasis 49Disease 49Mesothelioma 44Liver Neoplasms 44Pulmonary Disease, Chronic Obstructive 42Mesothelioma, Malignant 42Brain Neoplasms 37Lung Diseases 36Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Pleural Effusion, Malignant 34Kidney Neoplasms 33NSCLC 31Carcinoma 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Drug-Related Side Effects and Adverse Reactions × Thoracic × Clear all
NCT03125603 2019-02-19

Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Completed
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡